Contact

Our portfolio

PsyPhy

PsyPhy offers the PsyPhy Mobile Lab (PML), a comprehensive solution for recording neural activity and conducting behavioral research. The PML includes hardware, software, and subscription-based support for data analysis and education. PsyPhy aims to revolutionize neurophysiological education with accessible, high-quality equipment. The company addresses emerging markets for portable EEG and GSR devices.

  • Institute: University of Amsterdam
Industry: Diagnostics, Electronics, Medical Technology
  • Founding year: 2023
Visit website

Want to get in contact about PsyPhy?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

Rsouth Antibodies
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
AviSia Therapeutics
Modulating immune responses with glycan-modified antigens for the treatment of Type 1 Diabetes.
Anywyse
Transforming content into audio-based e-learning for on-the-go learning.
InSteps
Digitizing stroke treatment development and planning with an in-silico stroke simulation platform.
Rsouth Antibodies
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.
AviSia Therapeutics
Modulating immune responses with glycan-modified antigens for the treatment of Type 1 Diabetes.
Anywyse
Transforming content into audio-based e-learning for on-the-go learning.
InSteps
Digitizing stroke treatment development and planning with an in-silico stroke simulation platform.
Explore full AAV portfolio
Contact